Zobrazeno 1 - 10
of 17
pro vyhledávání: '"Eric Scott Schaefer"'
Autor:
Adam Abel, Alejandro Navarro, Lauren Averett Byers, Irfan Cicin, Mustafa Ozguroglu, Ji-Youn Han, Aimee Bence Lin, Samuel McNeely, Xuejing Wang, Melissa Lynne Johnson, Konstantin H. Dragnev, Scott M. Hynes, Eric Scott Schaefer, Igor Bondarenko, Martin Forster
Publikováno v:
Scientia
Background: This study assessed the checkpoint kinase 1 inhibitor prexasertib in patients with extensive-stage small-cell lung cancer (ED-SCLC). Patients and Methods: This was a parallel-cohort phase II study of 105 mg/m2 prexasertib once every 14 da
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ed4c18fc47f726ad124316f502641acd
https://hdl.handle.net/11351/7780
https://hdl.handle.net/11351/7780
Autor:
H. Halawani, D. Oubre, M. Khalil, J. Dubay, S. Boniol, Wallace Akerley, J. Orsini, J. Boyd, Emily K. Pauli, Paul R. Walker, N. Nagajothi, S. Sinha, Ray D. Page, Eric Scott Schaefer, R. Mitchell, Patricia Rich, Edgardo S. Santos, Nadeem Ikhlaque, J. Tan
Publikováno v:
Journal of Thoracic Oncology. 16:S1029-S1030
Autor:
D. Oubre, R. Brian Mitchell, J. Orsini, Edgardo S. Santos, Patricia Rich, Scott Boniol, Warren Brenner, Jonathan Goldberg, Waseemullah Khan, Suman Sinha, Savita Bidyasar, Eric Scott Schaefer, Emily K. Pauli, Paul R. Walker, Kan Huang, Andrea Veatch, Linda Traylor, Maria Quejada, Wallace Akerley, Mitchell Haut, Mazen Khalil, Bassam Ghabach, Ray D. Page, Hafez Halawani, Jason Keith Boyd, J. Dubay
Publikováno v:
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 10 (2021)
Journal for Immunotherapy of Cancer
Journal for Immunotherapy of Cancer
PurposeImmune checkpoint inhibition (ICI) therapy has improved patient outcomes in advanced non-small cell lung cancer (NSCLC), but better biomarkers are needed. A clinically validated, blood-based proteomic test, or host immune classifier (HIC), was
Autor:
Wallace Akerley, Ray D. Page, R. Brian Mitchell, Kan Huang, Mitchell Haut, Jason Keith Boyd, J. Dubay, Nagaprasad Nagajothi, Savita Bidyasar, J. Orsini, Mazen Khalil, Eric Scott Schaefer
Publikováno v:
Cancer Research. 81:662-662
Motivation. A blood-based proteomic host immune classifier (HIC) that identifies a patient's disease state as Hot or Cold can aid prognostication and help guide treatment decisions in non-small cell lung cancer (NSCLC). The HIC Hot label is associate
Autor:
Jeff Hunnicutt, Nathan I. Cherny, Eric Scott Schaefer, JT Beck, Michael A. Kolodziej, Shay Friedman, Philip Blumenfeld, Tracy Thurow, Lavi Kwiatkowsky, Gabrielle Ahlzadeh
Publikováno v:
Journal of Clinical Oncology. 39:1526-1526
1526 Background: Remote symptom monitoring of patients receiving cancer treatment has been shown to improve patient outcomes in the research setting. However, there is little evidence that this technology can be implemented and scaled in the real wor
Autor:
Christopher Conn, D. Ross Camidge, Yusuke Okuma, Tatiana Hernandez Guerrero, Satwant Lally, Melissa Lynne Johnson, Alona Zer, Xiaohua Xin, Julio Antonio Peguero, Lan Wang, Maria de Miguel, Edwin E. Jeng, Jair Bar, Shawn Jeffries, Daniel Morgensztern, Eric Scott Schaefer, Mor Moskovitz, Kiyotaka Yoh
Publikováno v:
Journal of Clinical Oncology. 39:TPS3142-TPS3142
TPS3142 Background: Protein tyrosine kinase 7 (PTK7) is a highly conserved receptor tyrosine kinase involved in the Wnt signaling pathway and is overexpressed in multiple cancer types, including non-small cell lung cancer (NSCLC). Cofetuzumab pelidot
Autor:
J. Dubay, Eric Scott Schaefer, M. Khalil, Paul R. Walker, D. Oubre, R. Mitchell, Wallace Akerley, J. Orsini, N. Nagajothi, J. Tan
Publikováno v:
Journal of Thoracic Oncology. 16:S211
Autor:
Patricia Rich, Edgardo S. Santos, Wallace Akerley, Eric Scott Schaefer, J. Dubay, N. Nagajothi, Paul R. Walker, Ray D. Page, J. Orsini, Emily K. Pauli, J. Tan, W. Brenner, R. Mitchell
Publikováno v:
Journal of Thoracic Oncology. 16:S160
Autor:
D. Oubre, Jiahuai Tan, Nadeem Ikhlaque, Hafez Halawani, Wallace Akerley, Jason Keith Boyd, J. Dubay, Emily K. Pauli, Scott Boniol, Paul R. Walker, Nagaprasad Nagajothi, Ray D. Page, Patricia Rich, Mazen Khalil, R. Brian Mitchell, Insight Investigators, Eric Scott Schaefer, J. Orsini, Edgardo S. Santos, Suman Sinha
Publikováno v:
Journal of Clinical Oncology. 38:9545-9545
9545 Background: Immune checkpoint inhibition (ICI) has improved outcomes for many treatment-naïve advanced non-small cell lung cancer (NSCLC) patients. However, better biomarkers are needed to predict patient response and guide treatment decisions
Autor:
P. Kellie Turner, Siva Rama Prasad Kambhampati, Anwar Hossain, Pilar Garrido, Eric Scott Schaefer, William J. John, Luis Paz-Ares, Martin Gutierrez, Shadia I. Jalal, Jonathan W. Goldman, Edward S. Kim, Erica L. Johnston, Richard P. Beckmann, Daruka Mahadevan, Monte Shaheen, Karen Kelly, Mariano Provencio
Publikováno v:
Kim, ES; Kelly, K; Paz-Ares, LG; Garrido, P; Jalal, S; Mahadevan, D; et al.(2018). Abemaciclib in Combination with Single-Agent Options in Patients with Stage IV Non-Small Cell Lung Cancer: A Phase Ib Study.. Clinical cancer research : an official journal of the American Association for Cancer Research. doi: 10.1158/1078-0432.ccr-18-0651. UC Davis: Retrieved from: http://www.escholarship.org/uc/item/44q4x16z
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 24, iss 22
Clinical cancer research : an official journal of the American Association for Cancer Research, vol 24, iss 22
Purpose: Abemaciclib, a dual inhibitor of cyclin-dependent kinases 4 and 6, has demonstrated preclinical activity in non–small cell lung cancer (NSCLC). A multicenter, nonrandomized, open-label phase Ib study was conducted to test safety, MTD, phar
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::74001a4c1ebc327e3042ef2e853fa4e0
http://www.escholarship.org/uc/item/44q4x16z
http://www.escholarship.org/uc/item/44q4x16z